» Articles » PMID: 20492516

Cholestasis Induces Apoptosis in Mice Cardiac Cells: the Possible Role of Nitric Oxide and Oxidative Stress

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2010 May 25
PMID 20492516
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Acute cholestasis is associated with cardiovascular complications. The purpose of the present study was to investigate the effect of cholestasis on heart apoptosis and the involvement of nitric oxide (NO) and oxidative stress in the possible altered apoptosis of cholestatic hearts.

Methods: Cholestasis was induced by bile duct-ligation, and sham-operated mice served as controls. Three days after the surgery, heart tissues were evaluated for apoptosis and the level of malondialdehyde (MDA), and the activities of catalase (CAT), glutathione peroxidase (GSHPx) and superoxide dismutase (SOD) have been studied in cardiac tissues. The role of treatment with l-NAME, a non-selective inhibitor of NO synthase, or with d-NAME, an inactive isomer of l-NAME, on cholestatic and sham cardiac apoptosis, level of MDA and CAT, SOD and GSHPx activities was also investigated. The content of NO in cardiac tissue was also determined.

Results: Cholestatic hearts showed structural abnormalities and increased apoptosis compared with sham hearts. Treatment with l-NAME, but not d-NAME, improved both structural abnormalities and enhanced apoptosis of cholestatic hearts. Cholestatic hearts also had an increased level of MDA and decreased activities of CAT and GSHPx, which were not modified by d-NAME treatment. By l-NAME treatment, the level of MDA decreased and activities of CAT, GSHPx and SOD increased in BDL mice. The content of NO was higher in cholestatic cardiac tissue, which was decreased by l-NAME treatment.

Conclusion: In conclusion, apoptosis in cholestatic heart might have occurred because of NO overproduction, which could induce oxidative stress in the heart of cholestatic mice.

Citing Articles

Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway.

Lashgari N, Khayatan D, Roudsari N, Momtaz S, Dehpour A, Abdolghaffari A Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1433-1454.

PMID: 37736835 DOI: 10.1007/s00210-023-02684-2.


Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis.

Najibi A, Rezaei H, Kumar Manthari R, Niknahad H, Jamshidzadeh A, Farshad O Clin Exp Hepatol. 2023; 8(3):195-210.

PMID: 36685263 PMC: 9850306. DOI: 10.5114/ceh.2022.119216.


Pulmonary inflammation, oxidative stress, and fibrosis in a mouse model of cholestasis: the potential protective properties of the dipeptide carnosine.

Ommati M, Sabouri S, Niknahad H, Arjmand A, Alidaee S, Mazloomi S Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(6):1129-1142.

PMID: 36651945 DOI: 10.1007/s00210-023-02391-y.


Acute myocardial injury secondary to severe acute liver failure: A retrospective analysis supported by animal data.

Uhlig M, Hein M, Habigt M, Tolba R, Braunschweig T, Helmedag M PLoS One. 2021; 16(8):e0256790.

PMID: 34460845 PMC: 8405020. DOI: 10.1371/journal.pone.0256790.


Chenodeoxycholic and deoxycholic acids induced positive inotropic and negative chronotropic effects on rat heart.

Gao J, Yuan G, Xu Z, Lan L, Xin W Naunyn Schmiedebergs Arch Pharmacol. 2020; 394(4):765-773.

PMID: 32808070 DOI: 10.1007/s00210-020-01962-7.